• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-5期慢性肾脏病、透析及移植后儿童镁和微量元素状况的评估与管理:儿科肾脏营养特别工作组的临床实践要点

Assessment and management of magnesium and trace element status in children with CKD stages 2-5, on dialysis and post-transplantation: Clinical practice points from the Pediatric Renal Nutrition Taskforce.

作者信息

Tuokkola Jetta, Anderson Caroline E, Collins Sheridan, Pugh Pearl, Vega Molly R Wong, Harmer Matthew, Harshman Lyndsay A, Nelms Christina L, Toole Barry, Desloovere An, Paglialonga Fabio, Polderman Nonnie, Renken-Terhaerdt José, Shroff Rukshana, Snauwaert Evelien, Stabouli Stella, Walle Johan Vande, Warady Bradley A, Shaw Vanessa, Greenbaum Larry A

机构信息

Clinical Nutrition Unit, Internal Medicine and Rehabilitation, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

出版信息

Pediatr Nephrol. 2025 May 17. doi: 10.1007/s00467-025-06759-5.

DOI:10.1007/s00467-025-06759-5
PMID:40379985
Abstract

Children and young people with chronic kidney disease (CKD) are at risk for deficiency or excess of magnesium and trace elements. Kidney function, dialysis, medication, and dietary and supplemental intake can affect their biochemical status. There is much uncertainty about the requirements of magnesium and trace elements in CKD, which leads to variation in practice. The Pediatric Renal Nutrition Taskforce is an international team of pediatric kidney dietitians and pediatric nephrologists, formed to develop evidence-based clinical practice points to improve the nutritional care of children with CKD. PICO (patient, intervention, comparator, and outcomes) questions led the literature searches, which were conducted to ascertain current biochemical status, dietary intake, and factors leading to requirements differing from healthy peers, and to guide nutritional care of children with CKD stages 2-5, on dialysis, and post-transplantation. We address the assessment and intervention of magnesium and the trace elements chromium, copper, fluoride, iodine, manganese, selenium, and zinc. We suggest routine biochemical assessment of magnesium. Trace element assessment is based on clinical suspicion of deficiency or excess and their risk factors, including accumulation, losses, medications, nutrient interactions, and comorbidities. In particular, we suggest assessing magnesium, copper, iodine, and zinc when growth is poor, and evaluating magnesium, copper, selenium, and zinc in the presence of proteinuria. A structured approach to magnesium and trace element management, including biochemical, physical, and dietary assessment, is beneficial in the paucity of evidence. Research recommendations are suggested.

摘要

患有慢性肾脏病(CKD)的儿童和青少年存在镁及微量元素缺乏或过量的风险。肾功能、透析、药物治疗以及饮食和补充剂摄入都会影响他们的生化状态。CKD患者对镁和微量元素的需求量存在很大不确定性,这导致了实际操作中的差异。儿科肾脏营养工作组是一个由儿科肾脏营养师和儿科肾病学家组成的国际团队,其成立目的是制定基于证据的临床实践要点,以改善CKD儿童的营养护理。PICO(患者、干预措施、对照和结局)问题引导了文献检索,检索旨在确定当前的生化状态、饮食摄入以及导致需求与健康同龄人不同的因素,并指导2 - 5期CKD、透析及移植后儿童的营养护理。我们阐述了镁以及微量元素铬、铜、氟、碘、锰、硒和锌的评估与干预。我们建议对镁进行常规生化评估。微量元素评估基于对缺乏或过量及其风险因素的临床怀疑,包括蓄积、丢失、药物治疗、营养物质相互作用和合并症。特别是,我们建议在生长发育不良时评估镁、铜、碘和锌,在存在蛋白尿时评估镁、铜、硒和锌。在证据不足的情况下,采用结构化方法管理镁和微量元素,包括生化、体格和饮食评估,是有益的。文中还提出了研究建议。

相似文献

1
Assessment and management of magnesium and trace element status in children with CKD stages 2-5, on dialysis and post-transplantation: Clinical practice points from the Pediatric Renal Nutrition Taskforce.2-5期慢性肾脏病、透析及移植后儿童镁和微量元素状况的评估与管理:儿科肾脏营养特别工作组的临床实践要点
Pediatr Nephrol. 2025 May 17. doi: 10.1007/s00467-025-06759-5.
2
Assessment and management of vitamin status in children with CKD stages 2-5, on dialysis and post-transplantation: clinical practice points from the Pediatric Renal Nutrition Taskforce.CKD 2-5 期、透析和移植后儿童维生素状态的评估和管理:儿科肾脏营养工作组的临床实践要点。
Pediatr Nephrol. 2024 Oct;39(10):3103-3124. doi: 10.1007/s00467-024-06303-x. Epub 2024 Apr 4.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
5
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常(CKD-MBD)的磷结合剂。
Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3.
6
Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation.多频生物阻抗仪在透析慢性肾脏病患者液体管理中的应用:系统评价和经济评估。
Health Technol Assess. 2018 Jan;22(1):1-138. doi: 10.3310/hta22010.
7
The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement.营养性维生素D在慢性肾脏病患儿及成人、接受透析的慢性肾脏病患者以及肾移植后患者的慢性肾脏病-矿物质和骨异常中的作用——一份欧洲共识声明
Nephrol Dial Transplant. 2025 Apr 1;40(4):797-822. doi: 10.1093/ndt/gfae293.
8
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
9
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
10
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾脏病患者的HMG辅酶A还原酶抑制剂(他汀类药物)
Cochrane Database Syst Rev. 2023 Nov 29;11(11):CD007784. doi: 10.1002/14651858.CD007784.pub3.

本文引用的文献

1
Magnesium Disorders.镁紊乱
N Engl J Med. 2024 Jun 6;390(21):1998-2009. doi: 10.1056/NEJMra1510603.
2
Zinc Supplementation Trial in Pediatric Chronic Kidney Disease: Effects on Circulating FGF-23 and Klotho.小儿慢性肾脏病锌补充试验:对循环成纤维细胞生长因子-23和klotho的影响
Can J Kidney Health Dis. 2024 Mar 13;11:20543581241234723. doi: 10.1177/20543581241234723. eCollection 2024.
3
Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights.镁与慢性肾脏病血管钙化:最新研究进展。
Int J Mol Sci. 2024 Jan 18;25(2):1155. doi: 10.3390/ijms25021155.
4
Does the Nutritional Intake and Diet Quality of Children With Chronic Kidney Disease Differ From Healthy Controls? A Comprehensive Evaluation.慢性肾脏病儿童的营养摄入和饮食质量与健康对照组有差异吗?全面评估。
J Ren Nutr. 2024 Jul;34(4):283-293. doi: 10.1053/j.jrn.2023.12.002. Epub 2023 Dec 19.
5
In Vitro Evaluation of Bioavailability of Se from Daily Food Rations and Dietary Supplements.每日食物配给和膳食补充剂中硒的生物利用度的体外评估。
Nutrients. 2023 Mar 21;15(6):1511. doi: 10.3390/nu15061511.
6
Serum Iodine and Bromine in Chronic Hemodialysis Patients-An Observational Study in a Cohort of Portuguese Patients.慢性血液透析患者的血清碘和溴——一项针对葡萄牙患者队列的观察性研究
Toxics. 2023 Mar 6;11(3):247. doi: 10.3390/toxics11030247.
7
Magnesium Administration in Chronic Kidney Disease.镁在慢性肾脏病中的应用。
Nutrients. 2023 Jan 20;15(3):547. doi: 10.3390/nu15030547.
8
The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD).镁补充对 CKD 患者血管钙化的影响:一项随机临床试验(MAGiCAL-CKD)。
J Am Soc Nephrol. 2023 May 1;34(5):886-894. doi: 10.1681/ASN.0000000000000092. Epub 2023 Feb 2.
9
Association of Zinc with Anemia.锌与贫血的关系。
Nutrients. 2022 Nov 20;14(22):4918. doi: 10.3390/nu14224918.
10
Severe iodine-induced hypothyroidism in an infant on peritoneal dialysis: A salient reminder of the Wolff-Chaikoff effect of iodine.一名接受腹膜透析的婴儿发生严重碘诱导的甲状腺功能减退:碘的 Wolff-Chaikoff 效应的显著警示
J Paediatr Child Health. 2023 Feb;59(2):381-384. doi: 10.1111/jpc.16276. Epub 2022 Nov 8.